Sanofi removed a website for epilepsy drug Epilim after a consumer complaint. The Medicines and Healthcare products Regulatory Agency (MHRA) investigated the complaint that the Sanofi website for ...
Sanofi has restarted production at a plant where manufacturing had to be halted to fix pollution issues. The interruption created spot shortages of seizure drugs Epilim and Depakote in some markets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback